Page 20 - 202013
P. 20

ABSTRACT    OBJECTIVE:To study the effects of Calpeptin inhibitor Calpeptin on the transformation and stemness markers
        expression induced by estradiol (E2 ),and to investigate its mechanism. METHODS:Taking human mammary epithelial cells
        MCF-10A as research object,transformed cells were induced by E2 treatment. Cells were divided into control group(0.1%DMSO),
        E2-transformed group(50 nmol/L),E2-transformed+Calpeptin group(50 nmol/L E2+1 μmol/L Calpeptin),then continuously treated
        with corresponding drug-containing culture medium for 15 generations. Then,MTT assay was used to determine the proliferation
        rate of cells(24,48 h);plate colony test was used to detect the Clone formation rate of cells;the number of sphere-forming cells
        was measured by suspension spheroidization test;mRNA expressions of stemness marker(CD44,Nanog,OCT4)and extracellular
        sigal-regulated kinase(ERK)were detected by RT-qPCR,and protein expressions of CD44,Nanog,OCT4 ,ERK and p-ERK
        were detected by Western blotting assay. Another E2-transformed cells were divided into control group(0.1%DMSO)and U0126
        (ERK inhibitor)group(10 μmol/L). Clone formation rate,the number of sphere-forming,protein expressions of CD44,Nanog,
        OCT4,ERK and p-ERK were determined with above methods,and to validate the relationship of ERK inhibition with transformed
        cell behavior and the expression of stemness markers. RESULTS:Compared with control group,proliferation rate and clone
        formation rate of E2 transformed group were increased significantly(P<0.01),and the number of sphere-forming was increased
        significantly(P<0.01);mRNA expression levels of CD44,Nanog,OCT4,ERK and protein expression levels of CD44,Nanog,
        OCT4 and p-ERK in cells were increased significantly(P<0.01). Compared with E2-transformed group,proliferation rate(24,48
        h) and clone formation rate of E2-transformed + Calpeptin group were decreased significantly (P<0.01),and the number of
        sphere-forming was decreased significantly (P<0.05);mRNA expression levels of CD44,Nanog,OCT4 ,ERK and protein
        expression levels of CD44,Nanog,OCT4,p-ERK in cells were decreased significantly(P<0.05 or P<0.01). After treated with
        ERK inhibitor U0126,clone formation rate of E2-transformed cells,the number of sphere-forming,protein expression levels of
        CD44,Nanog,OCT4 and p-ERK were increased significantly(P<0.05 or P<0.01). CONCLUSIONS:Calpeptin can inhibit the
        transformation and the expression of stemness markers of human mammary epithelial cells MCF-10A,and the mechanism of it may
        be associated with inhibiting the activation of Calpain-ERK signaling pathway.
        KEYWORDS      Calpeptin; Estradiol; Human mammary epithelial cells MCF-10A; Cell transformation; Stemness marker;
        Extracellular sigal-regulated kinase;Mechanism


            雌二醇(E2)是诱导乳腺癌发生的主要风险因素 ,                        导了上皮细胞转化以及癌细胞的迁移、增殖                   [10-12] 。但有
                                                      [1]
        其可通过激活雌激素受体(ER)或代谢产生有毒代谢产                           关Calpain是否介导了E2诱导的乳腺上皮细胞MCF-10A
        物,从而诱导乳腺上皮细胞转化以及癌变发生                    [2-3] 。相关   干性特征增强,尚未见文献报道。另有研究显示,细胞
        研究显示,乳腺肿瘤干细胞(BCSCs)在乳腺癌的发生、                         外信号调节激酶(ERK)信号通路的激活与细胞的恶性
                                                                        [13]
        维持、转移、治疗抵抗和复发中起着重要作用,而 E2与                          转化密切相关 。但 Calpeptin 是否能通过 ERK 通路干
        BCSCs 的产生密切相关 。人乳腺上皮细胞 MCF-10A                      预乳腺上皮细胞 MCF-10A 转化以及干性特征增强,也
                             [4]
        是一种非致瘤性乳腺上皮细胞,正常情况下其呈不规则                            同样尚未见文献报道。鉴于此,本研究旨在通过探讨
        多边形贴壁生长,且增殖缓慢;但经 E2 长期诱导后,                          Calpain 抑 制 剂 Calpeptin 对 E2 诱 导 乳 腺 上 皮 细 胞
        MCF-10A 细胞将失去上皮细胞相关特性,胞体变大,呈                        MCF-10A 转化及干性标志物(CD44、OCT4、Nanog)表
        长梭形贴壁生长,增殖能力增强,且具有一定的间质特                            达的影响,并通过探究 Calpain-ERK 信号通路在其中的
           [5]
        征 。近期有研究发现,E2 能诱导人乳腺上皮细胞                            介导作用,为阐明Calpeptin抑制E2诱导乳腺癌发生的作
        MCF-10A 的自我更新、多潜能分化等干性特征增强,促                        用机制提供参考。
        进该细胞向BCSCs转化 。                                      1 材料
                             [6]
            钙激活中性蛋白酶(Calcium-activated neutral prote-       1.1 仪器
        ase,缩写为“Calpain”)是一种 Ca 依赖型半胱氨酸蛋白                       ND2000 型超微量紫外分光光度计、2001HY-6003
                                    2+
        酶,主要成员有 Calpain-1 和 Calpain-2,可参与调控乳腺               型CO2细胞培养箱(美国Thermo Fisher Scientific公司);
        癌细胞的多种恶性生物学行为              [7-8] 。Calpeptin 是一种具    HH-W21-Cr600 型电热恒温水温箱、DW-86L486 型立式
        有细胞穿透性的 Calpain 抑制剂,据相关研究报道,Cal-                    超低温冰箱(青岛海尔特种电器有限公司);SW-CJ-2D
        peptin可通过抑制ER阳性乳腺癌细胞MCF-7中Calpain                   型超净工作台(苏州净化设备有限公司);FA2204N型电
        的活性,从而抑制细胞的迁移和侵袭 。本课题组前期                            子天平(上海菁海仪器有限公司);ZHWY-103D 型恒温
                                        [9]
        研究发现,在 E2诱导人乳腺上皮细胞 MCF-10A 转化的                      培 养 振 荡 器(上 海 智 城 分 析 仪 器 制 造 有 限 公 司);
                                            [10]
        过程中,通常伴随着 Calpain 活性的增强 。而 Calpain                  DYY-7C 型电泳仪(北京市六一仪器厂);Epoch 型全波
        活性增强在癌症的发生发展中具有重要作用,其参与介                            长酶标仪(美国Bio-Tek公司);CKX41型倒置显微镜(日


        ·1550  ·  China Pharmacy 2020 Vol. 31 No. 13                                中国药房    2020年第31卷第13期
   15   16   17   18   19   20   21   22   23   24   25